SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-062762
Filing Date
2017-10-18
Accepted
2017-10-18 16:34:55
Documents
8
Period of Report
2017-10-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-15165_178k.htm 8-K 47306
2 EX-3.1 a17-15165_17ex3d1.htm EX-3.1 67480
3 EX-3.2 a17-15165_17ex3d2.htm EX-3.2 148005
4 EX-10.1 a17-15165_17ex10d1.htm EX-10.1 140630
5 EX-10.2 a17-15165_17ex10d2.htm EX-10.2 141529
6 EX-10.3 a17-15165_17ex10d3.htm EX-10.3 142615
7 EX-10.4 a17-15165_17ex10d4.htm EX-10.4 140264
8 EX-10.5 a17-15165_17ex10d5.htm EX-10.5 139399
  Complete submission text file 0001104659-17-062762.txt   968578
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 171142933
SIC: 2834 Pharmaceutical Preparations